Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an announcement.
MindBio Therapeutics Corp. has launched an ambassador campaign for Booze AI, the first AI-driven, voice-activated blood alcohol concentration estimator designed for smartphones, tablets, and computers. This app aims to promote responsible drinking and prevent impaired driving by providing real-time insights into alcohol levels. The app, which uses a proprietary prediction model and machine learning techniques, is available for a 30-day free trial. Booze AI has proven effective in estimating BAC with high accuracy, offering a significant potential for intoxication detection and harm reduction.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biopharma/biotechnology company focused on developing innovative solutions in the mental health industry.
Average Trading Volume: 212,584
Technical Sentiment Signal: Sell
See more data about MBIO stock on TipRanks’ Stock Analysis page.